### 64948 Federal Register / Vol. 76, No. 202 / Wednesday, October 19, 2011 / Notices

Marija Manojlovic, University of Pittsburgh: Based on an inquiry
conducted and written admission obtained by the University of Pittsburgh (UP) and additional analysis conducted by ORI in its oversight review, ORI found that Ms. Marija Manojlovic, former graduate student, Department of Chemistry, UP, engaged in research misconduct in research supported by
National Institute of General Medical Sciences (NIGMS), National Institutes of Health (NIH), grant P50 GM067082, National Cancer Institute (NCI), NIH, grant P01 CA078039, National Institute of Mental Health (NIMH), NIH, grant U54 MH074411, and National Institute of Allergy and Infectious Diseases (NIAID), NIH, grant R01 AI033506.

ORI found that the Respondent engaged in research misconduct by falsifying and fabricating the synthesis and spectral data that were included in one (1) poster presentation and in one (1) pre-submission draft of a paper to be submitted for publication.

Specifically, ORI found that the Respondent knowingly falsified and fabricated the synthesis and characterization, largely in the form of manipulated 1H- and 13C–NMR spectral data, for five intermediate steps and the final product, 9-desmethylpleurotin, and presented these false results in a poster, ‘‘Efforts Towards the Total Synthesis of Pleurotin,’’ presented at the 2011 National Organic Symposium, and in a manuscript, ‘‘Total Synthesis of 9- desmethylpleurotin,’’ prepared for
submission to Angewandte Chemie
International Edition.

Ms. Manojlovic has voluntarily agreed for a period of three (3) years, beginning on September 26, 2011:

(1) To have her U.S. Public Health Service (PHS)-supported research supervised; Respondent agreed that prior to the submission of an application for PHS support for a research project on which her participation is proposed and prior to her participation in any capacity on PHS-supported research, she shall ensure that a plan for supervision of her duties is submitted to ORI for approval; the supervision plan must be designed to ensure the scientific integrity of her research contribution; Respondent agreed that she shall not participate in any PHS-supported research until such a supervision plan is submitted to and approved by ORI; Respondent agreed to maintain responsibility for compliance with the agreed upon supervision plan;

(2) That any institution employing her shall submit, in conjunction with each application for PHS funds, or report,manuscript, or abstract involving PHSsupported research in which she is involved, a certification to ORI that the data provided by Respondent are based on actual experiments or are otherwise legitimately derived and that the data, procedures, and methodology are accurately reported in the application, report, manuscript, or abstract; and

(3) To exclude herself from serving in any advisory capacity to PHS including, but not limited to, service on any PHS advisory committee, board, and/or peer review committee, or as a consultant.

**FOR FURTHER INFORMATION CONTACT :**  Director, Division of Investigative Oversight, Office of Research Integrity, 1101 Wootton Parkway, Suite 750, Rockville, MD 20852, (240) 453–8800.

John Dahlberg, Director, Division of Investigative Oversight, Office of Research Integrity.

[FR Doc. 2011–27022 Filed 10–18–11; 8:45 am]

**BILLING CODE 4150–31–P**

**DEPARTMENT OF HEALTH AND**
**HUMAN SERVICES**

**Decision To Evaluate a Petition To Designate a Class of Employees From**  **Oak Ridge National Laboratory (X–10), Oak Ridge, TN, To Be Included in the**  **Special Exposure Cohort**

**AGENCY :**  National Institute for Occupational Safety and Health (NIOSH), Department of Health and Human Services (HHS).

**ACTION :**  Notice.

**SUMMARY :**  HHS gives notice as required by 42 CFR 83.12(e) of a decision to evaluate a petition to designate a class of employees from Oak Ridge National Laboratory (X–10), Oak Ridge, Tennessee, to be included in the Special Exposure Cohort under the Energy Employees Occupational Illness Compensation Program Act of 2000. The initial proposed definition for the class being evaluated, subject to revision as warranted by the evaluation, is as
follows:

Facility: Oak Ridge National Laboratory (X–10)

Location: Oak Ridge, Tennessee. Job Titles and/or Job Duties: All contractor employees, subcontractor employees, and AEC employees who
were monitored or should have been monitored for any of the various radionuclides and fission products present at the X–10 plant.

Period of Employment: January 1, 1943 through December 31, 1952.

**FOR FURTHER INFORMATION CONTACT :**  Stuart L. Hinnefeld, Director, Division of Compensation Analysis and Support, National Institute for Occupational Safety and Health (NIOSH), 4676 Columbia Parkway, MS C–46, Cincinnati, OH 45226, Telephone 877– 222–7570. Information requests can also be submitted by e-mail to

DCAS@CDC.GOV.

John Howard,
Director, National Institute for Occupational Safety and Health.

[FR Doc. 2011–27035 Filed 10–18–11; 8:45 am]

**BILLING CODE 4163–19–P**

**DEPARTMENT OF HEALTH AND**
**HUMAN SERVICES**

**Agency for Healthcare Research and Quality** 

**Notice of Senior Executive Service**

**Performance Review Board Membership** 

The Agency for Healthcare Research and Quality (AHRQ) announces the appointment of members to the AHRQ Senior Executive Service (SES) Performance Review Board (PRB). This action is being taken in accordance with 5 U.S.C. 4314(c)(4), which requires notice of appointment of members to performance review boards to be published in the Federal Register.

Members of the PRB are appointed in a manner that will ensure consistency, stability and objectivity in the SES performance appraisals. The function of
the PRB is to make recommendations to the Director, AHRQ, relating to the performance of senior executives in the Agency.

The following persons will serve on the AHRQ SES Performance Review
Board:

Irene Fraser, Stephen B. Cohen, William Munier, David Meyers, Michael Fitzmaurice, Phyllis Zucker, Mark Handelman, Jean Slutsky.

For further information about the AHRQ Performance Review Board, contact Ms. Alison Reinheimer, Office of Performance, Accountability, Resources, and Technology, Agency for Healthcare Research and Quality, 540 Gaither Road, Suite 4012, Rockville, Maryland 20850.

Dated: October 2, 2011.
Carolyn M. Clancy,

Director, AHRQ.

[FR Doc. 2011–26965 Filed 10–18–11; 8:45 am]

**BILLING CODE 4160–90–M**